Results 1 to 10 of about 157,660 (290)

Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial. [PDF]

, 2020
BACKGROUND: Skin barrier dysfunction precedes eczema development. We tested whether daily use of emollient in the first year could prevent eczema in high-risk children. METHODS: We did a multicentre, pragmatic, parallel-group, randomised controlled trial
BEEP study team, Boyle, RJ, Bradshaw, LE, Brown, SJ, Chalmers, JR, Cork, MJ, Davies-Jones, S, Flohr, C, Haines, RH, Jay, N, Kelleher, MM, Lawton, S, Mitchell, EJ, Montgomery, AA, Perkin, MR, Ridd, MJ, Sach, TH, Simpson, EL, Swinden, R, Tarr, S, Thomas, KS, Williams, HC   +21 more
core   +7 more sources

Hidden gems: a pilot project to solicit and reward patients’ and caregivers’ ideas for research

Research Involvement and Engagement, 2023
Background Patients and caregivers investigate a wide range of approaches to address the signs and symptoms of their condition. Such investigation could lead to new treatment insights or avenues for research.
Freya Moxham, Christine Cutaran, Jakub Sadocha, Korey Capozza   +3 more
doaj   +1 more source

Burden of adult atopic dermatitis and unmet needs with existing therapies

Journal of Dermatological Treatment, 2023
Objective Patients with atopic dermatitis (AD) have low treatment satisfaction. In this study, we evaluated the humanistic burden, treatment satisfaction, and treatment expectations in patients with AD in the United States.
Elizabeth D. Bacci, Julia R. Correll, Evangeline J. Pierce, Amber Reck Atwater, Zach Dawson, Wendy Smith Begolka, Lisa Butler   +6 more
doaj   +1 more source

Factors Associated with Eczema Clinical Trial Awareness, Interest, and Participation in Adults

Acta Dermato-Venereologica, 2023
Despite the need for improved eczema therapies and a rapid increase in available eczema clinical trials, participation remains low. The aim of this study was to identify factors associated with clinical trial awareness, interest, and barriers to ...
Erin E. Grinich, Isabelle J. Thibau, Emile Latour, Kyla N. Price, Allison R. Loiselle, Eric Simpson, Wendy Smith Begolka   +6 more
doaj   +1 more source

Study of Hypersensitivity to Malassezia furfur in Patients with Atopic Dermatitis with Head and Neck Pattern: Is It Useful as a Biomarker and Therapeutic Indicator in These Patients?

Life, 2022
Atopic dermatitis (AD) is one of the most prevalent chronic inflammatory diseases. Head and neck (H&N) involvement, also known as the picture-frame pattern, can be a diagnostic and even therapeutic challenge. Sensitization to the fungus Malassezia furfur
Francisco José Navarro-Triviño, Ángela Ayén-Rodríguez   +1 more
doaj   +1 more source

The financial burden of out‐of‐pocket healthcare expenses on caregivers of children with atopic dermatitis in the United States

Skin Health and Disease, 2023
Background Atopic dermatitis (AD) is associated with elevated financial costs, including out‐of‐pocket (OOP) expenses. Yet, the full burden of OOP expenses in children with AD is poorly understood. Objectives We sought to characterise categories, impact,
Raj Chovatiya, Wendy Smith Begolka, Isabelle J. Thibau, Jonathan I. Silverberg   +3 more
doaj   +1 more source

‘It's like the bad guy in a movie who just doesn't die’ : a qualitative exploration of young people's adaptation to eczema and implications for self‐care [PDF]

, 2019
Background Eczema is a common childhood inflammatory skin condition, affecting more than one in five children. A popular perception is that children ‘outgrow eczema’, although epidemiological studies have shown that, for many, eczema follows a lifelong ...
Ghio, D, Greenwell, K, Langan, SM, McNiven, A, Muller, I, Roberts, A, Santer, M   +6 more
core   +3 more sources

Economic evidence for the prevention and treatment of atopic eczema: a protocol for a systematic review [PDF]

, 2016
Background: Eczema, synonymous with atopic eczema or atopic dermatitis, is a chronic skin disease that has a similar impact on health-related quality of life as other chronic diseases.
AS Paller, Centre for reviews and dissemination (CRD), D Husereau, H Nankervis, H Williams, HC Williams, J Buchanan, J Glanville, J Kay, JK Schofield, JM Batchelor, KLE Hon, L Shamseer, M Futamura, RM Emerson, RM Herd, S Lewis‐jones, Z Philips, Z Philips   +18 more
core   +1 more source

Do early-life exposures explain why more advantaged children get eczema? Findings from the U.K. Millennium Cohort Study [PDF]

, 2015
Background: Atopic dermatitis (eczema) in childhood is socially patterned, with higher incidence in more advantaged populations. However, it is unclear what factors explain the social differences.
Hope, S., Law, C., Pearce, A., Taylor-Robinson, D.C., Williams, H.   +4 more
core   +1 more source

Measurement properties of quality of life measurement instruments for infants, children and adolescents with eczema: protocol for a systematic review [PDF]

, 2016
Background: Eczema is a common chronic or chronically relapsing skin disease that has a substantial impact on quality of life (QoL). By means of a consensus-based process, the Harmonising Outcome Measures in Eczema (HOME) initiative has identified QoL as
AD Furlan, CB Terwee, CB Terwee, CB Terwee, CJ Apfelbacher, CJ Apfelbacher, CL Carroll, HC Williams, J Schmitt, J Schmitt, J Schmitt, J Schmitt, J Schmitt, JJ Grob, JM Schellingerhout, L Shamseer, LB Mokkink, LB Mokkink, LB Mokkink, LF Eichenfield, M Boers, PR Williamson, S Lewis-Jones, T Bieber   +23 more
core   +2 more sources